Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Denver-Aurora, CO Metro Edition
Focus: LIFE SCI
Denver regulatory pay softens as clinical trial talent tightens.
3.9%
Denver-Aurora unemployment rate
vs 4.1% national rate, mid-2026
0.6%
Colorado job growth, 2026 projected
17,500 jobs, 3rd month of state losses
$97,512
Regulatory Affairs Specialist pay, metro
down significantly, below $104,000 national
$97,530
Clinical Research Associate pay, metro
up significantly, above $90,956 national
This Month's Takeaways
Regulatory affairs pay is softening locally against national scarcity.
Metro Regulatory Affairs Specialist pay dropped to $97,512, a significant decline that now sits below the $104,000 national median even as senior regulatory leadership commands six-figure premiums nationally. This divergence may signal Denver employers normalizing mid-level regulatory pay while the real scarcity concentrates at VP and director levels.
CRA compensation reversed the usual metro discount.
Denver's $97,530 median for Clinical Research Associates now exceeds the $90,956 national figure, an unusual inversion that is consistent with intensifying local clinical trial activity competing for a thin pipeline of experienced CRAs. Organizations building out clinical operations headcount should expect this premium to persist rather than treat it as a one-month anomaly.
Manufacturing build-out signals a bet against CDMO dependency.
The Colorado BioScience Institute's projection of 218-plus entry-level manufacturing openings across 13 employers points toward regional employers favoring in-house bioprocess capacity over outsourcing, even as national CMC director pay climbs to $220K-$520K. Metro Validation Engineer pay rising moderately to $111,831 supports this reading — build strategies are being funded, not just discussed.
Tight labor supply narrows who gets hired, not just how much they cost.
Colorado's 0.6% projected job growth alongside sub-4% metro unemployment means generalist and administrative roles face less pressure than specialized clinical, regulatory, and bioprocess positions. Headcount plans built around broad hiring volume may need re-weighting toward mission-critical specialist roles rather than proportional growth across functions.
Local Labor Conditions
Denver-Aurora's unemployment rate held near 3.9% through mid-2026 even as Colorado posted its third straight month of statewide job losses, leaving the metro meaningfully tighter than the 4.1% national rate and signaling that life sci employers compete in a labor pool more constrained than headline state figures suggest. Median annual pay growth of 5.8% across Denver-Aurora-Lakewood, paired with Denver's minimum wage climbing to $19.29/hour, is compressing pay differentials between entry-level and specialized roles and forcing recalibration of internal pay bands.
Leadership & Talent Implications
Regulatory Affairs Specialist advertised pay fell to a metro median of $97,512 — down significantly and now trailing the $104,000 national figure — even as national VP-level regulatory compensation holds at $320K-$580K, suggesting Denver's regulatory talent pool is bifurcating between scarce senior leadership and a softening mid-career segment that may ease some hiring pressure. Clinical Research Associate pay, by contrast, climbed to $97,530 locally against a $90,956 national median, a reversal of the usual metro discount that points to acute local competition for clinical operations talent likely tied to GLP-1 and biotech clinical trial expansion. Consider reviewing regulatory affairs compensation bands against the current downward local trend before assuming parity with national scarcity narratives, while treating CRA retention as a nearer-term pressure point.
